Abstract:Background Doxorubicin (Dox) is a potent anticancer drug with severe side effects to normal tissues. To fabricate a nanomedicine with Dox is a better method to address the side effects of Dox in normal tissues. However, nanomedicines with unapproved materials could not be easily applied in clinic, hence, a nanomedicine fabricated by endogenous materials is a potential method to increase the possibility of clinical application. Methods In this study, a redox-responsive nanomedicine with clinical-applied anticancer of Dox and endogenous molecule of l-glutathione oxidized (GSSG) was prepared for cancer therapy.: The carboxyl and amino groups in l-glutathione oxidized can be reacted itself to form the poly-l-glutathione oxidized peptide-like polymer. Meanwhile, the Dox were conjugated in poly-l-glutathione oxidized polymer by amnio group in Dox and the structure of Dox-conjugated poly-l-glutathione oxidized polymer (Dox-Poly GSSG) was confirmed by FT-IR, NMR and MALDIT-TOF. Afterward, the drug loading of Dox (22 %) in poly-GSSG was measured by UV–vis and the accumulative Dox release rate of Dox-Poly GSSG is 46 % in 5 mg/mL reduced glutathione (GSH) environment at 72 h The size stability of Dox-Poly GSSG in PBS and PBS with GSH was evaluated by dynamic laser scatter (DLS) and transmit emission microscopy (TEM). Furthermore, cell viabilities of Dox-Poly GSSG were similar with free Dox evaluated by CCK-8 assay and flow cytometry experiment, respectively. The distribution of Dox-Poly GSSG in nuclei and tumor tissues was evaluated by Confocal laser scanning microscope and in vivo imaging system, respectively. Significant Findings The drug release results showed that the Dox could be controllable released in high concentration of GSH in tumor tissues. The tumor inhibition, H&E and TUNEL experiments showed that the Dox-Poly GSSG group can significantly inhibit the tumor growth compared to saline group and avoid major side effects to normal tissues compared to free Dox. This redox-responsive nanomedicine with clinical-applied anticancer of Dox and endogenous molecule of GSSG is a potential candidate for clinical application.

Ph and Reduction Dual-Responsive Nanogel Cross-Linked by Quaternization Reaction for Enhanced Cellular Internalization and Intracellular Drug Delivery

Two-archive method for aggregation-based many-objective optimization

Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan

Full analytical solution of Adapted Polarisation State Contrast Imaging.

Redox/pH Dual Stimuli-Responsive Biodegradable Nanohydrogels with Varying Responses to Dithiothreitol and Glutathione for Controlled Drug Release

Photo, Ph and Redox Multi-Responsive Nanogels for Drug Delivery and Fluorescence Cell Imaging

Ionic Microgel Loaded with Gold Nanoparticles for the Synergistic Dual-Drug Delivery of Doxorubicin and Diclofenac Sodium

[Complications in intravenous alimentation (author's transl)].

Delivery of doxorubicin in vitro and in vivo using bio-reductive cellulose nanogels

Reduction-Responsive Drug Delivery Based on Mesoporous Silica Nanoparticle Core with Crosslinked Poly(Acrylic Acid) Shell

Folate-conjugated Poly(n-(2-hydroxypropyl)methacrylamide-co-methacrylic Acid) Nanohydrogels with Ph/redox Dual-Stimuli Response for Controlled Drug Release

Dual-responsive Doxorubicin-Loaded Nanomicelles for Enhanced Cancer Therapy.

Temperature and Redox Dual‐Responsive Biodegradable Nanogels for Optimizing Antitumor Drug Delivery

Redox/pH Stimuli-Responsive Biodegradable PEGylated P(MAA/BACy) Nanohydrogels for Controlled Releasing of Anticancer Drugs

pH-responsive nanogels with enhanced antioxidant and antitumor activities on drug delivery and smart drug release

Schiff base-containing dextran nanogel as pH-sensitive drug delivery system of doxorubicin: Synthesis and characterization

Multi-responsive nanogels containing motifs of ortho ester, oligo(ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs.

Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging

Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors.

Redox-responsive nanomedicine of doxorubicin-conjugated poly-L-glutathione oxidized for cancer therapy

β-cyclodextrin-modified carboxymethyl chitosan/hyaluronic acid-based crosslinked composite nanogels as a dual responsive carrier for targeting anti-tumor therapy